Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Actidil
2. Anhydrous, Triprolidine Hydrochloride
3. Hydrochloride Anhydrous, Triprolidine
4. Hydrochloride, Triprolidine
5. Pro Actidil
6. Triprolidine
7. Triprolidine Hydrochloride Anhydrous
8. Triprolidine Monohydrochloride
9. Triprolidine Monohydrochloride, (z)-isomer
10. Triprolidine Monohydrochloride, Monohydrate
11. Triprolidine Oxalate
12. Triprolidine Oxalate, (trans)-isomer
13. Triprolidine, (z)-isomer
1. 550-70-9
2. Actidilat
3. Venen
4. Actidil
5. Trans-triprolidine Hydrochloride
6. Pro-actidil
7. Pro-entra
8. Triprolidine Hydrochloride Anhydrous
9. 6138-79-0
10. Entra
11. (e)-2-(3-(pyrrolidin-1-yl)-1-(p-tolyl)prop-1-en-1-yl)pyridine Hydrochloride
12. Triprolidine Hydrochloride (anhydrous)
13. Mls000028751
14. Ng7a104r3j
15. Chebi:84119
16. Pyridine, 2-(1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, Monohydrochloride, (e)-
17. Smr000058521
18. Triprolidine (hydrochloride)
19. Triprolidine Hydrochloride (anh.)
20. Sr-01000075292
21. Einecs 208-985-0
22. Unii-ng7a104r3j
23. Pyridine, 2-((1e)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl)-, Monohydrochloride
24. Prestwick_575
25. Mfcd00039044
26. Opera_id_1214
27. (e)-2-[3-(1-pyrrolidinyl)-1-p-tolylpropenyl]pyridine Hydrochloride
28. Trans-2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)pyridine Monohydrochloride
29. Schembl42145
30. Mls001148254
31. Mls002207213
32. Mls002222226
33. Spectrum1500598
34. Chembl1200450
35. Hy-b1808a
36. Dtxsid10872513
37. Hms1568f06
38. Hms1921i07
39. Hms3411o04
40. Hms3675o04
41. Pharmakon1600-01500598
42. Triprolidine Hydrochloride, >=99%
43. Tox21_501130
44. Ccg-40331
45. Nsc757361
46. Triprolidine Monohydrochloride (anh.)
47. Akos015962154
48. Lp01130
49. Triprolidine Monohydrochloride Anhydrous
50. Pyridine, 2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)-, Monohydrochloride, (e)-
51. Ncgc00094397-01
52. Ncgc00094397-02
53. Ncgc00094397-03
54. Ncgc00261815-01
55. Ac-15905
56. As-13971
57. Triprolidine Monohydrochloride (anhydrous)
58. Anhydrous Triprolidine Hydrochloride
59. Triprolidine Hydrochloride [who-dd]
60. Cs-0013855
61. Eu-0101130
62. T 6764
63. 138t790
64. A868718
65. A923663
66. Anhydrous Triprolidine Hydrochloride [mart.]
67. Sr-01000075292-1
68. Sr-01000075292-3
69. Sr-01000075292-7
70. Triprolidine Hydrochloride, Sigma Reference Standard
71. Q27157492
72. (e)-2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)pyridine Monohydrochloride
73. (e)-2-(3-(pyrrolidin-1-yl)-1-(p-tolyl)prop-1-en-1-yl)pyridinehydrochloride
74. (e)-2-[1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propenyl]pyridine Hydrochloride
75. 1-[(2e)-3-(4-methylphenyl)-3-(pyridin-2-yl)prop-2-en-1-yl]pyrrolidinium Chloride
76. 2-[(1e)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridine Hydrochloride
Molecular Weight | 314.9 g/mol |
---|---|
Molecular Formula | C19H23ClN2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 4 |
Exact Mass | 314.1549764 g/mol |
Monoisotopic Mass | 314.1549764 g/mol |
Topological Polar Surface Area | 16.1 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 336 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6178
Submission : 1986-01-23
Status : Inactive
Type : II
Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17902
Submission : 2004-10-14
Status : Active
Type : II
Date of Issue : 2022-06-08
Valid Till : 2025-07-14
Written Confirmation Number : WC-0093
Address of the Firm :
NDC Package Code : 57218-900
Start Marketing Date : 2003-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19019
Submission : 2005-12-08
Status : Active
Type : II
Date of Issue : 2022-06-14
Valid Till : 2025-09-02
Written Confirmation Number : WC-0094nA2A
Address of the Firm :
NDC Package Code : 66651-906
Start Marketing Date : 2015-01-23
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5287
Submission : 1984-02-17
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10648
Submission : 1993-12-20
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17887
Submission : 2004-12-21
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2630
Submission : 1976-02-19
Status : Inactive
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2512
Submission : 1975-09-02
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6178
Submission : 1986-01-23
Status : Inactive
Type : II
Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17902
Submission : 2004-10-14
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4992
Submission : 1983-06-21
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2630
Submission : 1976-02-19
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10648
Submission : 1993-12-20
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5287
Submission : 1984-02-17
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2714
Submission : 1976-07-21
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8947
Submission : 1991-01-25
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2512
Submission : 1975-09-02
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5871
Submission : 1985-06-13
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Malladi is a leader in Ephedrine, Pseudoephedrine Salts & Phenylephrine HCl // USFDA, EDQM, ANSM, KFDA, and TGA inspected.
Triprolidine Hydrochloride(USP,BP, IP)
Date of Issue : 2022-06-08
Valid Till : 2025-07-14
Written Confirmation Number : WC-0093
Address of the Firm : Unit-3, 7B & 7C, SICOT Industrial Complex, Ranipet 632 403, Ranipet District, Ta...
Triprolidine Hydrochloride (IP/USP/BP)
Date of Issue : 2019-06-17
Valid Till : 2022-06-16
Written Confirmation Number : WC-0030
Address of the Firm : Unit-II, Annavaram(Post), Chippada Village, Beemunipatnam Mandal, Visakhapatan...
Triprolidine Hydrochloride USP/BP
Date of Issue : 2022-06-14
Valid Till : 2025-09-02
Written Confirmation Number : WC-0094nA2A
Address of the Firm : Plot No . 72 & 82/A, KIADB Industrial Area, Jigani, Anekal Taluk, Bengaluru-560 ...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Dosage Form : Gel
Grade : Not Available
Brand Name : Kollisolv PEG 1000
Application : Topical
Excipient Details : Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG
Dosage Form : Suppository
Grade : Not Available
Brand Name : Kollisolv PEG 1450
Application : Thickeners and Stabilizers
Excipient Details : Forms anhydrous, hydrophilic ointments in combination with low mol. weight PEG
Dosage Form : Emulsion
Grade : Not Available
Brand Name : Kollisolv PEG 300
Application : Solubilizers
Excipient Details : Liquid plasticizer, solvent for oral and topical applications, hydrophilic fill for solubilization of hydrophilic APIs.
Pharmacopoeia Ref : Ph. Eur., JP, FCC, USP
Technical Specs : Not Available
Ingredient(s) : Polyethylene Glycol 300
Dosage Form : Tablet
Grade : Not Available
Brand Name : Kollisolv PEG 400
Application : Solubilizers
Excipient Details : Liquid plasticizer, Solvent for oral and topical applications, Hydrophilic fill for solubilization of hydrophilic APIs.
Pharmacopoeia Ref : Ph. Eur., JP, FCC, USP
Technical Specs : Not Available
Ingredient(s) : Polyethylene Glycol 400
Dosage Form : Softgel Capsule
Grade : Not Available
Brand Name : Kollisolv PEG 600
Application : Solubilizers
Excipient Details : Hydrophilic fill for solubilization of hydrophilic APIs.
Pharmacopoeia Ref : Ph. Eur., JP, FCC, USP
Technical Specs : Not Available
Ingredient(s) : Polyethylene Glycol 600
Dosage Form : Tablet
Grade : Not Available
Application : Film Formers & Plasticizers
Excipient Details : Liquid plasticizer with high ADI, hydrophilic solvent & humectant in emulsions, skin penetration enhancer in topical formulaitons.
Pharmacopoeia Ref : Ph. Eur., JP, FCC, USP
Technical Specs : Not Available
Ingredient(s) : Propylene Glycol
Dosage Form : Softgel Capsule
Grade : Not Available
Application : Thickeners and Stabilizers
Excipient Details : Structure-building consistency factor with dry feel, forms crystalline barrier on skin
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP: Stearic ...
Technical Specs : Not Available
Ingredient(s) : Stearic Acid
Dosage Form : Tablet
Grade : Not Available
Application : Granulation
Dosage Form : Granule / Pellet
Grade : Not Available
Application : Direct Compression
Excipient Details : Ready-to-use direct compression solution for tablets.
Dosage Form : Granule / Pellet
Grade : Not Available
Application : Direct Compression
Excipient Details : Ready-to-use direct compression solution for lozenges, chewables and effervescent tablets.
Pharmacopoeia Ref : Ph. Eur., USP/NF and J.P
Technical Specs : Not Available
Ingredient(s) : Lactose
Dosage Form : Tablet
Grade : Oral
Brand Name : SEPIFILM Classic Range
Application : Coating Systems & Additives
Excipient Details : Coating
Dosage Form : Tablet
Grade : Oral
Application : Coating Systems & Additives
Excipient Details : Coating
Dosage Form : Tablet
Grade : Oral
Brand Name : SEPIFILM LP Range
Application : Coating Systems & Additives
Excipient Details : Coating, Moisture Protection
Pharmacopoeia Ref : Ph.Eur, USP-NF, JPE
Technical Specs : EXCiPACT
Ingredient(s) : HPMC Based Granules
Dosage Form : Tablet
Grade : Oral
Brand Name : SEPIFILM PW Range
Application : Coating Systems & Additives
Excipient Details : Coating
Dosage Form : Tablet
Grade : Oral
Application : Coating Systems & Additives
Excipient Details : Coating
Pharmacopoeia Ref : Not Available
Technical Specs : EXCiPACT
Ingredient(s) : HPMC & Sugar Based Granules
Dosage Form : Tablet
Grade : Oral
Brand Name : SEPISPERSE Dry Range
Application : Coating Systems & Additives
Excipient Details : Coloring Agents
Dosage Form : Granule / Pellet
Grade : Oral
Application : Direct Compression
Excipient Details : Capsule Filling, Direct Compression, Binding, Disintegration
Pharmacopoeia Ref : Not Available
Technical Specs : EXCiPACT
Ingredient(s) : Native & Pregelatinized Corn Starch
Excipients by Applications
Market Place
Reply
06 May 2022
Reply
08 Apr 2022
Reply
26 Dec 2019
Reply
09 Oct 2019
Reply
10 Oct 2018
Reply
13 Sep 2018
REF. STANDARDS & IMPURITIES
Triprolidine Hydrochloride (300 mg)
CAS Number : 6138-79-0
Quantity Per Vial :
Price ($) : 230
Catalog Number : 1696007
Current Lot : I1K365
Previous Lot : I (31-JAN-2013)
NDC Code :
Triprolidine Hydrochloride Z-Isomer (50 mg)
CAS Number : N/A
Quantity Per Vial :
Price ($) : 730
Catalog Number : 1696109
Current Lot : I0M185
Previous Lot : H0I096 (30-APR-2014)
NDC Code :
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?